355 related articles for article (PubMed ID: 20220779)
1. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
Pellagatti A; Cazzola M; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Killick S; Verma A; Norbury CJ; Hellström-Lindberg E; Wainscoat JS; Boultwood J
Leukemia; 2010 Apr; 24(4):756-64. PubMed ID: 20220779
[TBL] [Abstract][Full Text] [Related]
2. Lenalidomide induces cell death in an MDS-derived cell line with deletion of chromosome 5q by inhibition of cytokinesis.
Matsuoka A; Tochigi A; Kishimoto M; Nakahara T; Kondo T; Tsujioka T; Tasaka T; Tohyama Y; Tohyama K
Leukemia; 2010 Apr; 24(4):748-55. PubMed ID: 20130600
[TBL] [Abstract][Full Text] [Related]
3. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
Chen L; Li J; Zhu Y; Qiu H; Pan J; Wang R; Qian S; Xu W; Xue Y
Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
5. The molecular pathogenesis of the myelodysplastic syndromes.
Pellagatti A; Boultwood J
Eur J Haematol; 2015 Jul; 95(1):3-15. PubMed ID: 25645650
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
Boultwood J; Pellagatti A; Cattan H; Lawrie CH; Giagounidis A; Malcovati L; Della Porta MG; Jädersten M; Killick S; Fidler C; Cazzola M; Hellström-Lindberg E; Wainscoat JS
Br J Haematol; 2007 Nov; 139(4):578-89. PubMed ID: 17916100
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome.
Qian J; Chen Z; Wang W; Cen J; Xue Y
Oncol Rep; 2005 Nov; 14(5):1189-97. PubMed ID: 16211284
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes.
del Rey M; O'Hagan K; Dellett M; Aibar S; Colyer HA; Alonso ME; Díez-Campelo M; Armstrong RN; Sharpe DJ; Gutiérrez NC; García JL; De Las Rivas J; Mills KI; Hernández-Rivas JM
Leukemia; 2013 Mar; 27(3):610-8. PubMed ID: 22936014
[TBL] [Abstract][Full Text] [Related]
9. Identification of defects in the transcriptional program during lineage-specific in vitro differentiation of CD34(+) cells selected from patients with both low- and high-risk myelodysplastic syndrome.
Gueller S; Komor M; Nowak D; Baldus CD; de Vos S; Hoelzer D; Ottmann OG; Hofmann WK
Exp Hematol; 2010 Sep; 38(9):718-32, 732.e1-6. PubMed ID: 20621626
[TBL] [Abstract][Full Text] [Related]
10. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.
Nilsson L; Astrand-Grundström I; Anderson K; Arvidsson I; Hokland P; Bryder D; Kjeldsen L; Johansson B; Hellström-Lindberg E; Hast R; Jacobsen SE
Blood; 2002 Jul; 100(1):259-67. PubMed ID: 12070035
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic analysis in patients with myelodysplastic syndrome.
Hu N; Bian M
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):135-9. PubMed ID: 2098765
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic findings in adult greek myelodysplastic syndrome patients: predominance of single trisomy 8.
Panani AD
In Vivo; 2006; 20(1):115-8. PubMed ID: 16433038
[TBL] [Abstract][Full Text] [Related]
13. Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q.
Schoch C; Kohlmann A; Dugas M; Kern W; Hiddemann W; Schnittger S; Haferlach T
Leukemia; 2005 Jul; 19(7):1224-8. PubMed ID: 15902281
[TBL] [Abstract][Full Text] [Related]
14. [Chromosomal aberrations in myelodysplastic syndrome].
Ol'shanskaia IuV; Domracheva EV; Udovichenko AI; Vodinskaia LA; Zakharova AV; Parovichnikova EN; Tsvetaeva NV; Mikhaĭlova EA; Glasko EN; Kolosova LIu; Kokhno AN; Tikhonova LIu; Shitareva TV; Smirnova EA; Alimova GA; Shirin AD; Vinogradova OIu; Khoroshko ND; Savchenko VG
Ter Arkh; 2005; 77(7):27-33. PubMed ID: 16116905
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study.
Pitchford CW; Hettinga AC; Reichard KK
Am J Clin Pathol; 2010 Feb; 133(2):260-4. PubMed ID: 20093235
[TBL] [Abstract][Full Text] [Related]
16. Changes associated with lenalidomide treatment in the gene expression profiles of patients with del(5q).
Belickova M; Cermak J; Dostalova Merkerova M; Vesela J; Krejcik Z; Cechova E; Zemanova Z; Michalova K; Votavova H; Caniga M; Neuwirtova R; Jonasova A
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):375-83. PubMed ID: 22608605
[TBL] [Abstract][Full Text] [Related]
17. Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
Pellagatti A; Benner A; Mills KI; Cazzola M; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Verma A; McDonald EJ; Killick S; Hellström-Lindberg E; Bullinger L; Wainscoat JS; Boultwood J
J Clin Oncol; 2013 Oct; 31(28):3557-64. PubMed ID: 24002510
[TBL] [Abstract][Full Text] [Related]
18. Aberrant microRNA expression pattern in myelodysplastic bone marrow cells.
Hussein K; Theophile K; Büsche G; Schlegelberger B; Göhring G; Kreipe H; Bock O
Leuk Res; 2010 Sep; 34(9):1169-74. PubMed ID: 20627384
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.
Lee HR; Oh B; Hong DS; Zang DY; Yoon HJ; Kim HJ; Kim I; Ahn JS; Cheong JW; Lee KA; Cho KS; Lee MH; Bang SM; Kim TY; Yun YM; Min YH; Lee YK; Lee DS;
Cancer Genet Cytogenet; 2010 Dec; 203(2):193-202. PubMed ID: 21156233
[TBL] [Abstract][Full Text] [Related]
20. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
